MDNA Life Sciences (UK) Ltd is a privately held limited company established in 2005, operating from A6 Kingfisher House, Kingsway, Gateshead, NE11 0JQ, UK. The company’s registration number is 05386828 and is currently active. MDNA specializes in research and experimental development within the biotechnology sector, focusing on novel compounds and formulations. The company’s core business revolves around providing bespoke research services to pharmaceutical, biotech, and research institutions globally. MDNA’s expertise encompasses a range of analytical and synthetic chemistry techniques, including peptide synthesis, chiral separations, and custom formulation development. While primarily focused on UK-based operations, MDNA Life Sciences (UK) Ltd maintains an international presence through a network of skilled scientists and technicians. The company’s size is estimated to be moderate, with a significant emphasis on innovation and client-driven projects. MDNA’s key focus is on delivering high-quality, tailored solutions to meet specific research needs. The company’s international business mobility status indicates a commitment to global collaboration and talent acquisition. The company’s SIC codes include: - 72110 (Research and experimental development on biotechnology) and - 72111 (Contract research services).

MDNA Life Sciences (UK) Ltd is a privately held limited company established in 2005, operating from A6 Kingfisher House, Kingsway, Gateshead, NE11 0JQ, UK. The company’s registration number is 05386828 and is currently active. MDNA specializes in research and experimental development within the biotechnology sector, focusing on novel compounds and formulations. The company’s core business revolves around providing bespoke research services to pharmaceutical, biotech, and research institutions globally. MDNA’s expertise encompasses a range of analytical and synthetic chemistry techniques, including peptide synthesis, chiral separations, and custom formulation development. While primarily focused on UK-based operations, MDNA Life Sciences (UK) Ltd maintains an international presence through a network of skilled scientists and technicians. The company’s size is estimated to be moderate, with a significant emphasis on innovation and client-driven projects. MDNA’s key focus is on delivering high-quality, tailored solutions to meet specific research needs. The company’s international business mobility status indicates a commitment to global collaboration and talent acquisition. The company’s SIC codes include: - 72110 (Research and experimental development on biotechnology) and - 72111 (Contract research services).